Professor Alberto Bernabe -
The John Marshall Law School
Thursday, June 3, 2010
Lawsuit claims Wyeth targeted African Americans illegally for off label use of drug
Pharmalot is reporting that two former hospital sales reps have filed a whistleblower suit alleging Wyeth, which is now owned by Pfizer, illegally promoted its Rapamune kidney transplant drug for use with other organs and targeted African-Americans, even though this is a high-risk patient group. Go here for the full story.